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Abstract
Background: Viruses are important components of microbial communities modulating community structure and
function; however, only a couple of tools are currently available for phage identification and analysis from
metagenomic sequencing data. Here we employed the random forest algorithm to develop VirMiner, a web-based
phage contig prediction tool especially sensitive for high-abundances phage contigs, trained and validated by
paired metagenomic and phagenomic sequencing data from the human gut flora.
Results: VirMiner achieved 41.06% ± 17.51% sensitivity and 81.91% ± 4.04% specificity in the prediction of phage
contigs. In particular, for the high-abundance phage contigs, VirMiner outperformed other tools (VirFinder and
VirSorter) with much higher sensitivity (65.23% ± 16.94%) than VirFinder (34.63% ± 17.96%) and VirSorter (18.75% ±
15.23%) at almost the same specificity. Moreover, VirMiner provides the most comprehensive phage analysis
pipeline which is comprised of metagenomic raw reads processing, functional annotation, phage contig
identification, and phage-host relationship prediction (CRISPR-spacer recognition) and supports two-group
comparison when the input (metagenomic sequence data) includes different conditions (e.g., case and control).
Application of VirMiner to an independent cohort of human gut metagenomes obtained from individuals treated
with antibiotics revealed that 122 KEGG orthology and 118 Pfam groups had significantly differential abundance in
the pre-treatment samples compared to samples at the end of antibiotic administration, including clustered
regularly interspaced short palindromic repeats (CRISPR), multidrug resistance, and protein transport. The VirMiner
webserver is available at http://sbb.hku.hk/VirMiner/.
Conclusions: We developed a comprehensive tool for phage prediction and analysis for metagenomic samples.
Compared to VirSorter and VirFinder—the most widely used tools—VirMiner is able to capture more high-
abundance phage contigs which could play key roles in infecting bacteria and modulating microbial community
dynamics.
Trial registration: The European Union Clinical Trials Register, EudraCT Number: 2013-003378-28. Registered on 9
April 2014
Keywords: Phage, Metagenome, Phage-host interaction, Antibiotics
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: msom@bio.dtu.dk; gipa@hku.hk; Gianni.Panagiotou@hki-
jena.de
5Bacterial Synthetic Biology Section, Novo Nordisk Foundation Center for
Biosustainability, Technical University of Denmark, Kemitorvet, 2800 Kongens
Lyngby, Denmark
4Department of Systems Biology and Bioinformatics, Leibniz Institute for
Natural Product Research and Infection Biology, Hans Knöll Institute (HKI),
Beutenbergstraße 11a, 07745 Jena, Germany
Full list of author information is available at the end of the article
Zheng et al. Microbiome            (2019) 7:42 
https://doi.org/10.1186/s40168-019-0657-y
Introduction
Viruses are essential constituents of microbial communi-
ties contributing to their homeostasis and evolution. The
viral community in the human gut flora is dominated by
bacteriophages [1]. Phages can modulate the structure
and function of a bacterial community through horizon-
tal gene transfer (HGT) [2], thereby altering the bacterial
phenotypes including virulence, antibiotic resistance,
and biofilm formation [3–5]. Such phage-induced alter-
ations could pose potential health risks by influencing
bacterial pathogenicity and antibiotic resistance. For in-
stance, phages affect virulence of facultative pathogens
like Vibrio cholera [6]; several phage-encoded virulence
factors have been discovered such as Shiga-like toxin [7],
which was shown to induce apoptosis in many cell types
[8, 9]. Meanwhile, the role of phages in the proliferation
of antibiotic resistance is still controversial. Tradition-
ally, phages were considered as a genetic reservoir for
bacterial adaptations under stress, such as antibiotic
treatment. It has been demonstrated experimentally that
antibiotic-resistance genes were highly enriched in
phages from antibiotic-treated mice [10]. However, in a
recent study [11], researchers concluded that the pres-
ence of antibiotic resistance genes (ARG) was vastly
overestimated in phage genomes. Through an explora-
tory bioinformatics strategy, they identified two known
and 421 newly predicted ARGs in 1181 publicly available
phage genomes. However, their experimental tests ex-
pressing four predicted ARGs in Escherichia coli did not
lead to increased antibiotic resistance. The inconsistent
findings indicate that the role of phages in the prolifera-
tion of antibiotic resistance and human health remains
poorly understood.
Even though bacteriophages represent a significant
part of health-related viral communities, to get a deeper
understanding of phages remains challenging due to the
difficulties in virus isolation and purification [12–14].
Yet, the use of metagenomic sequencing, which gener-
ates simultaneously genome reads from both prokaryotic
cells and viruses, has promoted the viral studies dramat-
ically by recovering phage genomes from metagenomes
of ecological and clinical samples [15–17]. Using this ap-
proach, a set of potential gut-specific Bacteroidales-like
phages was identified within human gut microbial ge-
nomes [17], which also encode antibiotic resistance
genes. Another study classified and quantified the phage
taxa contained within fecal metagenomes from 207 indi-
viduals worldwide using taxon-specific marker genes
[18] and found differences in the abundances of particu-
lar phage taxa across human populations. Therefore, the
taxonomic and functional compositions of phageome
and the phage-host interactions could be revealed using
directly the metagenomic data. Furthermore, a better
ecological understanding of the microbiomes and deeper
insights of their impacts on human health could be
achieved.
Identifying phage contigs from mixed bacterial and
phage sequences is a necessary and critical step for
phage analysis in metagenomic studies. Most of the
current tools for identifying phage sequences or pro-
phage regions, including Phage Finder [19], Prophage
Finder [20], Prophinder [21], and PHAST [22], are only
suitable for virome sequencing or prokaryotic genome
sequencing data, but not designed for identifying phage
sequences from metagenomic data and cannot efficiently
separate phage and bacterial sequences from micro-
biome. Metaphinder [23] is a web server developed to
process metagenomic sequencing data to identity phage
contigs. Nevertheless, all these aforementioned tools
identify phage sequences through homology search
against known phage sequences in current databases. As
it is estimated that there are 1031 viral particles infecting
microbial communities, only a few thousand viral ge-
nomes are deposited in the current databases [24, 25].
Thus, the current tools might ignore a large number of
unknown or uncultured phages.
To achieve the prediction of unknown phages from
metagenomic data, VirSorter [26] and VirFinder [12]
were recently developed. VirSorter has employed two
reference databases of viral protein sequences to detect
the presence of “hallmark” genes defined as text match-
ing “major capsid protein,” “portal,” “terminase large
subunit”, “spike,” “tail,” “virion formation,” or “coat” an-
notations for each metagenomic contigs. Besides, VirSor-
ter uses other metrics including viral-like genes,
Pfam-affiliated genes, short genes, and depletion in
strand switching to build a probabilistic model to meas-
ure the confidence level of the predicted viral region.
Based on this, the metagenomic contigs can be classified
into three categories: sequences having significant en-
richment in viral-like genes and viral hallmark genes de-
tected (“most confident”), sequences having either
significant enrichment in viral-like genes or viral hall-
mark genes detected (“likely”), and sequences dissimilar
with known virus references but structurally similar with
known viral genomes (“possible”). In contrast, VirFinder
empirically hypothesizes that viruses and phages have
discernibly different k-mer frequency, so a k-mer-based
machine learning model was built to determine viral sig-
nals in metagenomic samples. Both tools have presented
good predictive performance. However, the performance
evaluation was based on simulated metagenomes [12,
26], which were generated by artificially setting the pro-
portion of viral contigs, thus it cannot reflect the pre-
dictive ability on actual samples. Our analysis revealed
that the composition used to evaluate the aforemen-
tioned tools is significantly different from the real micro-
biome composition in the human gut, which may result
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in biased predictions. Besides, the functions offered by
VirSorter and VirFinder for phage analysis within micro-
bial communities are relatively limited; after identifying
phage contigs, no further analysis is provided, such as
phage-host interaction, which may reveal the key role of
phages in response to particular stress. Therefore, a
more powerful tool is needed to provide a deeper under-
standing of the possible role of phages within microbial
communities.
Here, we developed VirMiner, a user-friendly web tool
that employs the random forest model to identify phage
contigs, especially for high-abundance phage contigs,
from metagenomic data. To achieve higher predictive
power in real metagenomic data, VirMiner was trained
and evaluated by a human gut microbial metagenomes,
with paired phageomes from purified phage libraries
generated from 10 individuals treated with antibiotics
and longitudinal sampling. Moreover,VirMiner provides
a comprehensive analysis pipeline which includes several
highlights: (1) raw reads processing, on-site metagenome
assembly, and gene prediction; (2) comprehensive func-
tional annotations including Pfam, KEGG orthology
(KO), phage orthologous groups (POG), viral protein
families, and viral hallmarks; (3) a highly sensitive ran-
dom forest (RF) predictive model for phage contig iden-
tification, which shows outstanding performance in the
identification of high-abundance phage contigs; (4)
phage-host relationship prediction and CRISPR-site rec-
ognition; and (5) statistical comparisons between differ-
ent sample groups.
Materials and methods
Updated POG database
Our updated phage orthologous groups (uPOGs) data-
base was built in October 2016 using the same method-
ology as Kristensen et al. [27], except that we integrated
more recently released and published phage genomes to
gain more POGs. The sequences of 3319 publicly avail-
able phage genomes were acquired from the NCBI nu-
cleotide (https://www.ncbi.nlm.nih.gov/nuccore/?term=)
using same keywords as Kristensen et al. [27], besides,
759 prophage genomes were downloaded from
ACLAME database [28]. These phage genomes used for
uPOGs construction are available in our website (http://
147.8.185.62/VirMiner/downloads/phage_genome/). The
sequences of 7734 available prokaryotic genomes depos-
ited in NCBI were also downloaded. POGs were con-
structed using the standard COG-building method [29].
Among these constructed POGs, we further identified
virus-specific POGs based on virus quotient (VQ) com-
putation [27]. All POGs were mapped against phage ge-
nomes and prokaryotic genomes, respectively, using
psi-blast (E value ≤ 0.001, bit score > 40, homologous re-
gion ≥ 40 amino acids). The prokaryotic genomes with
prophage regions as identified by PhiSpy [30] were ex-
cluded from the virus quotient (VQ) calculation. For
each POG, VQ was calculated as the quotient of the fre-
quency of matches to viral genomes versus the sum of
the frequency of matches to both viral and prokaryotic
genomes. POGs with VQ > 0.85 were considered as
highly virus-specific POGs. We also identified
taxa-specific POGs that can be used to detect the pres-
ence of specific taxon groups. For the POG database de-
veloped by Kristensen et al. [27] (POG 2012), results
were presented using two different criteria: (a) 100% re-
call, 100% precision, and a VQ of 1.0 and appeared in
only a single copy per genome in the POGs; (b) 100%
precision threshold, the VQ threshold at 1.0, but using
no recall threshold. In another study that employed the
POG database for human gut microbiome analysis [18],
Waller et al. used the criteria of 100% precision, VQ
greater than 85%, recall greater than 85%, and being
present in a single copy per genome. Here we followed
the criteria of Waller et al. [18] for taxon signature POG
identification. The update of POGs database (uPOGs) is
available on our website (http://147.8.185.62/VirMiner/
downloads/updated_POG_database/). A more detailed
description of these methods is available in Kristensen et
al. [27].
Ethics statement
Written informed consent was obtained from all partici-
pants involved in the study. The study was approved by
the local ethics committee in Region Zealand, Denmark
(REG-026-2014) and performed in accordance with the
Good Clinical Practice principles and the Helsinki dec-
laration. Details of the study were published before study
start at the clinical trials register (www.clinicaltrialsregis-
ter.eu; EudraCT nr.: 2013-003378-28).
Study design of training dataset
A total of 10 healthy individuals were included in this
study. After randomization, eight individuals were
treated with different antibiotics (azithromycin for 5 days
(N = 2), doxycycline for 7 days (N = 2), cefuroxime for 5
days (N = 2), or ciprofloxacin for 5 days (N = 2)), and two
individuals referred to as controls received no medica-
tion (Additional file 1: Table S1 for subject information).
Fecal samples were obtained at various time points: one
time point before (15 days before treatment), two time
points during (third and fifth day of antibiotic treatment
± 1 day), and three time points after treatment (15, 30,
and 90 days after treatment ± 1 day). Control delivered
fecal samples with similar intervals. In total, 59 samples
were used for sequencing both microbial metagenomes
and paired phageomes (for one sample collected at 15
days post cefuroxime treatment high-quality libraries
could not be obtained). Samples used in this study are
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identical to those in Kang et al. (in preparation), there-
fore the metagenomic and phageome sequencing data
will be released together with the companion
manuscript.
Microbial DNA extraction
DNA was extracted from 5-g aliquots of frozen stool
using the MO BIO PowerMax Soil DNA Extraction Kit
(MO BIO Laboratories, Inc) according to the manufac-
turer’s protocol with a few modifications. As a control
for DNA extraction, E. coli MG1655 carrying pZE21
plasmid supplemented with mCherry gene was used.
Overnight E. coli culture (37 °C, 180 rpm) in LB broth
was prepared. Five milliliters of overnight culture was
used for DNA extraction following the same protocol
used for DNA extraction from fecal samples. DNA sam-
ples were stored at − 20 °C.
Microbial DNA purification
After extraction, the DNA was purified (PowerClean®
Pro DNA Clean-Up Kit, MO BIO Laboratories, Inc.) ac-
cording to the manufacturer’s protocol. When necessary,
the isolated DNA was concentrated to > 50 ng/uL using
a vacuum concentrator (Concentrator plus, Eppendorf).
The quantity of the DNA was measured using Qubit® 2.0
Fluorometer (Thermo Fisher Scientific Inc.). The quality
of the DNA was measured using NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific), and the
size was examined by gel electrophoresis, analyzing 5 μl
of the DNA on a 1% (w/v) agarose gel, containing Red-
Safe™ Nucleic Acid Staining Solution (iNtRON
Biotechnology).
Microbial DNA library preparation and sequencing
DNA samples were sent to Macrogen (South Korea) for
library preparation and sequencing (Illumina Hiseq 2000
PE125). DNA library for sequencing was prepared by
using TrueSeq Nano 550 bp kit (Illumina). Two hundred
nanograms was used as input template according to sup-
plied kit instructions. Sequencing depth was set up to a
minimum of 6 Gb of data per sample.
Phage DNA extraction
Phage particles were isolated from 5-g aliquots of frozen
stool. Fifty milliliters of PBS containing calcium and
magnesium was added to the aliquots, and the samples
were homogenized on vortex for 20 min at highest speed
(SI-H506, Horizontal 50-mL Tube Holder, Scientific In-
dustries). Then, the samples were centrifuged three
times at 4 °C: 2 min at 872×g, 10 min at 3800×g, and 20
min at 7500×g. After each centrifugation step, the super-
natant was transferred into new 50-ml Falcon tube and
the pellet was discarded. Ten milliliters of the super-
natant was filtered through 0.22-μm filters (EMD
Millipore Sterivex-GP SVGPL10RC Polyethersulfone Fil-
ter Unit, Millipore). To concentrate the virus particles,
the filtered supernatant was concentrated to 1 ml by
centrifugation in 100 Da Amicon Ultra filters (Amicon
Ultra-15 Centrifugal Filter Units, Millipore) at 3488×g at
15 °C. The supernatant was filtered through a 0.45-μm
syringe filter (Cellulose acetate membrane syringe filter,
Filter Technology) into a 1.5-ml phase lock gel tube (5
PRIME), and 40 μL of lysozyme (10 mg/mL,
Sigma-Aldrich) was added, and the filtrate was incubated
for 30 min at 37 °C under shaking at 300 rpm. After in-
cubation, 400 μL of chloroform was added to the sam-
ples and the samples were incubated for 15 min at room
temperature. The samples were centrifuged at 14.000×g
for 5 min at room temperature, and the supernatant was
transferred to a 1.5-ml Eppendorf tube. A mix of DNases
and RNase containing 500 U of bovine pancreas DNase I
recombinant (Roche), 33 U of Baseline-ZERO™ DNase
(Epicenter), 6 U of Salt Active Nuclease (ArcticZymes),
and 500 U of RNase A (Roche) were added to the sam-
ples with 100 μl of 10× incubation buffer (Roche). The
samples were incubated at 37 °C for 90 min, and then, at
75 °C for 10 min. After the DNase/RNase treatment, the
phage particles were stored overnight at 4 °C. The phage
DNA was extracted using Phage DNA Isolation Kit
(46,850, Norgen Biotek) according to the manufacturer’s
protocol. As a control sample for phage DNA extraction,
15 ml of lambda phage lysates sample was used. The
quantity of the DNA was measured using Qubit® 2.0
Fluorometer (Thermo Fisher Scientific Inc.). Phage DNA
samples were stored at − 80 °C.
Preparation of phage lysate
A 100-ml culture of lambda phage lysogen E. coli K-12
strain MC1061 was grown from single colonies in LB
broth at 37 °C, 180 rpm. Phage lambda was labeled with
spectinomycin resistance gene aadA (WP_010891332.1)
(Fogg et al. 2010). Upon reaching the exponential growth
phase, determined by an optical density at 600 nm of 0.4,
mitomycin C (Sigma) was added to a final concentration
of 0.5 μg/ml. Lysogenic cultures were incubated overnight
at 37 °C, 180 rpm in the dark. The cultures were centri-
fuged at 4.000×g for 10min, and the supernatants were
filtered through low protein binding 0.22-μm pore size
membrane filters (Millex-GP, Millipore, Bedford, MA).
Phage lysate was stored at 4 °C until use.
Phage library preparation and sequencing
Phage DNA libraries were prepared using the KAPA
HyperPlus Kit (Kapa Biosystems). All steps were con-
ducted on ice except the two cleanups, which were per-
formed at room temperature. The concentration was
measured using Qubit® 2.0 Fluorometer (Thermo Fisher
Scientific Inc.), and the size of the library was examined
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using Bioanalyzer (Agilent 2100 Bioanalyzer system, Agi-
lent Technologies). The library (average size between
500 and 900 bp) were pooled and sequenced on MiSeq
platform (PE300).
User data preprocessing
The preprocessing of input data (metagenomic raw reads in
FASTQ format) includes mainly three steps (Fig. 1): (1) for
the uploaded data, adaptor region, low-quality bases/reads,
and PCR-duplicated reads are removed as previously de-
scribed [31, 32], the script is available on GitHub (https://
github.com/TingtZHENG/VirMiner/); (2) the short reads
are assembled into contigs using IDBA_UD with default
parameters [33]; due to computational memory constrains
of the VirMiner server, for user input data, metagenome as-
sembly is performed independently for each sample rather
than co-assembly; and (3) hidden Markov models (HMMs)
from MetaGeneMark [34] are used for gene prediction.
Functional annotation
We used different blast tools to search the predicted
ORFs against multiple databases with an e-value cutoff
of 1e-5: BLASTP against KEGG orthology (KO) [35] and
viral hallmark genes [26], BLASTPGP against POG 2012
and uPOGs, and RPSBLAST against the conserved do-
main database (CDD) profiles [36] to annotate with
Pfam [37]. The predicted genes were mapped against
viral protein families [24] by hmmsearch (E value <
1e-5). These functional profiles were used as the metrics
in building the RF model to identify phage contigs.
Microbial metagenomes and paired phageomes used in
the RF model training
The microbial metagenomes and paired phageomes were
used to build the model of phage contigs identification.
We defined three categories for metagenomic contigs:
phage contigs, ambiguous contigs, and confident
non-phage contigs. The metagenomic contigs were first
mapped against the contigs from the phageomic data for
the same sample using megablast (E value < 1e-5, iden-
tity > 98%). A metagenomic contig is marked as a phage
contig if it is present in the phageomic data and meets
at least one of the following criteria: (1) > 80% coverage
(aligned length/the length of the query or the subject
contig, which is shorter); and (2) aligned length > 10 kb.
The contigs defined as ambiguous should meet one of
following criteria: (1) 40–80% coverage, (2) aligned
length between 4 kb and 10 kb. Other than the above
two categories, the remaining ones were defined as
confident non-phage contigs.
Predictors used in the random forest (RF) model
Each contig was characterized using multiple features:
(1) average depth (the number of reads mapped to a
Fig. 1 The workflow of VirMiner. The high-quality reads are assembled into contigs using IDBA_UD [33]. HMM model from GeneMark [34] was
used for gene prediction. Functional profiles are generated by searching against different databases including KO, Pfam, and viral protein families
defined by Paez-Espino et al. [24], POG 2012, and uPOGs. The R package randomForest was employed to identify phage contigs. The taxonomy
affiliations of identified phage contigs are identified using the RDP classifier. Phage-host interaction prediction was performed using the CRISPR-
spacer based method
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contig divided by contig length), (2) the number of pre-
dicted genes, (3) the number of genes mapped to the up-
dated POG database, (4) the number of genes mapped
to viral protein families defined by Paez-Espino et al.
[24], (5) the percentage of genes annotated to viral pro-
tein families (the number of predicted genes annotated
to viral protein families divided by the total number of
predicted genes for this contig), (6) the number of genes
mapped to KO, (7) the percentage of genes annotated to
KO, (8) the number of genes mapped to Pfam, (9) the
percentage of genes annotated to Pfam, and (10) the
number of genes mapped to viral hallmark genes defined
in Roux et al. [26]. Only contigs > 5 kb were used to
build the predictive model (with the R package random-
Forest) and for downstream analysis.
Predictive performance evaluation
The metagenomic datasets were split into training and
test sets. A strategy similar to 10-fold cross-validation
was followed to train and evaluate the predictive model.
In each of the 10 steps, one of the 10 subjects was used
as the test set in turn and the other nine subjects were
pooled as the training set. Then the average predictive
performance across all 10 subjects was computed. To
overcome the imbalance of the contig classification (the
putative non-phage contigs (223,021 in total) outnum-
bered the putative phage contigs (4515 in total)) when
using RF, the training set was constructed by taking all
the putative phage contigs, ambiguous contigs, and ran-
domly selected 3000 confident non-phage contigs with
abundance in the top 50th percentile. The parameters
for the RF model were set as mtry = 7, ntree = 1500.
Two measurements were introduced to evaluate the
predictive performance: (1) the count of contigs pre-
dicted correctly, and (2) the abundance of contigs (rep-
resented by ratio of reads mappable to contigs) that
could be predicted correctly. The relative abundance of
each contig was defined as the proportion of total reads
mapped to the predicted contig, calculated as follows:
firstly, clean reads were mapped to the predicted contig
using Burrows-Wheeler Aligner (BWA) [38], then the
mapped reads were identified with identity 99%, and fi-
nally the number of mapped reads per contig was di-
vided by total reads in the sample. When evaluating the
predictive performance, the putative ambiguous contigs
and confident non-phage contigs were both considered
as non-phage contigs.
Phage-host interaction prediction
The CRISPR-spacer-based method is used for phage-host
relationship prediction. Firstly, all the assembled contigs
are mapped to prokaryotic genomes downloaded from
NCBI by blastn (E value < 1e-5). Afterwards, the CRISPR
recognition tool (CRT) [39] is employed to identify
spacers from bacterial contigs. All identified spacers are
searched against identified phage contigs using
blastn-short function from the Blast+ package [40] (e
value 1e− 10, max_target_seqs 1, identity 95%), following
Paez-Espino et al. [24].
Taxonomy affiliation for identified phage contigs
We employed the Ribosomal Database Project (RDP)
classifier [41], a Naive Bayes classifier, to classify the
identified phage contigs into different taxonomic levels.
Originally it was developed for classifying bacterial
rRNA sequences into the new bacterial taxonomy [41].
The classifier was developed based on the frequency of
all possible eight-base subsequences in training set with
known taxonomy information. Therefore, it is also suit-
able to search for the taxonomy affiliation of identified
phage contigs in our case. The sequences of 3319 avail-
able phage genomes downloaded from NCBI were used
to train the classifier. The taxonomy information was ex-
tracted according to the NCBI GenBank taxonomy. The
identified phage contigs were assigned to different tax-
onomy groups using the trained model. The taxonomy
assignments with estimated confidence level of ≤ 0.5
were discarded.
Differential abundance analysis
The abundance of each phage contig is quantified using
transcripts per kilobase per million reads (TPM). Wil-
coxon rank-sum test is used to detect differentially
abundant KO or Pfam categories when the input meta-
genomic samples cover two different conditions (e.g.,
case and control).
Microbial diversity analysis
For the metagenomic dataset, we calculated the number
of operational taxonomic units (OTUs) at both the
genus and species levels for each sample based on the
taxonomy affiliation of identified phage contigs assigned
by RDP classifier [41]. The microbial diversity indices in-
cluding Shannon index, Simpson index, and Pielou even-
ness index were calculated using the R package vegan
[42] at both the genus and species levels. Wilcoxon
rank-sum test is employed for inter-group comparisons.
Application of VirMiner in an independent dataset
The metagenomic dataset from Raymond et al. [43] con-
taining 24 healthy individuals was used. Eighteen indi-
viduals out of the 24 were treated for 7 days with
cefprozil, and six individuals, unexposed to antibiotics,
referred to as controls. Fecal samples were obtained at
various time points: before treatment (exposed 0 and
control 0), at the end of treatment (exposed 7 and con-
trol 7), and 90 days after the end of the treatment (ex-
posed 90 and control 90). The metagenomic raw reads
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were downloaded from the European Nucleotide Arch-
ive database in the project PRJEB8094.
Results
Updated phage orthologous groups (uPOGs) database
The majority of the POGs in the database initially devel-
oped in 2012 by Kristensen et al. [27] (POG2012) are
virus-specific, with low homology regions compared to
prokaryotic genomes. Moreover, POG2012 also identified
the taxon signature genes of phages. Therefore, it is suit-
able to be used for functional annotation of phage pro-
teins, identification of phages, and specific phage taxon
groups within mixed metagenomic data. With rapid
increase in phage genomes, updating the POG resource is
necessary to keep pace with the data generation. In an up-
dated POG database (pVOGs) [44] that was published in
2016, the identification of virus-specific POGs and taxon
signature genes is missing. Thus, in uPOGs, we integrated
more recently released and published phage genomes to
identify virus-specific POGs and taxa-specific marker
genes using the previously developed method [27].
In this study, we collected 4078 phage genomes and an-
notated 357,460 phage proteins (“Materials and methods”
section), which were subsequently clustered into 16,710
POGs. Compared to the two previous POG databases [27,
44], more orthologous groups and phage proteins were in-
cluded (Table 1). We further identified virus-specific
POGs that can help to distinguish prophage genes from
other components in microbial genomes, based on the
virus quotient (VQ), which was measured as the quotient
of the frequency of matches to viral genome [27]. A POG
with VQ close to 1 suggests that this POG is highly
virus-specific. The distributions of VQ values in the POG
2012 and our updated POG database were comparable
(Additional file 2: Table S2). In total, 11,978 virus-specific
POGs were provided, which outnumbered previous data-
bases (Additional file 2: Table S2).
Following the criteria of 100% precision, VQ greater
than 85%, recall greater than 85%, and being present in a
single copy per genome [18], we identified 640 taxon
signature POGs (assigned to 32 taxon groups) which
could serve as markers to identify the presence of par-
ticular taxon groups (“Materials and methods” section).
Compared to previous reports (106 POGs for 40 taxa in-
cluding 5 unclassified taxa) [18], more taxon marker
genes were identified, while the number of taxon groups
slightly decreased (32 vs 40).
VirMiner: a comprehensive tool for phage analysis in
metagenomic samples
As the workflow shown in Fig. 1, VirMiner allows users
to upload metagenomic raw reads in FASTQ format,
then it automatically processes the data including
low-quality reads filtering, metagenomic assembly, and
gene prediction. We built a predictive model to identify
phage contigs based on the uPOGs and other genomic
information. Firstly, co-assembly was performed by pool-
ing all sequencing reads from different samples of the
same individual for both metagenomic and phageomic
data independently. A total of 3,745,889 metagenomic
contigs and 41,711 phageomic contigs were yielded. We
then identified 4515 putative phage contigs, 1880 am-
biguous contigs and 221,141 confident non-phage con-
tigs (“Materials and methods” section, Additional file 3:
Table S3). A RF model was trained using all phage con-
tigs, ambiguous contigs, and 3000 non-phage contigs in
a manner similar to 10-fold cross-validation (“Materials
and methods” section).
We used sensitivity, specificity, precision, F1 score, ac-
curacy, and MCC (Matthews correlation coefficient) to
evaluate the predictive performance of our RF model in
different contig lengths (Additional file 4: Table S4, Add-
itional file 5: Table S5, and Additional file 6: Table S6).
Two measurements were used in the statistics of evalu-
ation: the number of correctly predicted contigs and the
ratio of reads mapped to the correctly predicted contigs.
For contigs longer than 5 kb, our RF model showed
41.06% ± 17.51% sensitivity and 81.91% ± 4.04% specifi-
city in the prediction of phage contigs. For the
high-abundance phage contigs, the model achieved
65.23% ± 16.94% sensitivity and 79.50% ± 6.46% specifi-
city (Additional file 4: Table S4). We also acquired simi-
lar performance for contigs longer than 1 kb and 3 kb
(Additional file 5: Table S5 and Additional file 6: Table
S6), indicating that VirMiner is a comprehensive tool for
phage analysis from metagenomic samples.
Comparison of VirMiner with other tools
VirMiner is a phage analysis pipeline providing various
features. The functional annotation includes the predic-
tion of KO, Pfam, viral hallmark genes, viral protein
families, and POG. As described above, VirMiner uses a
prebuilt predictive model to identify phage contigs from
all metagenomic contigs and performs downstream ana-
lyses including phage-host relationship prediction, tax-
onomy analysis, and inter-group comparisons. The
functionality comparison of different tools, such as Vir-
Sorter and VirFinder (Table 1), reveals that VirMiner is
a powerful and user-friendly web server, which is easy to
be handled especially for researchers without strong pro-
gramming skills.
Table 1 Statistics for different POG databases
uPOGs pVOGs POG 2012
Genomes 4078 2993 1027
Proteins 357,460 295,653 97,731
POGs 16,710 9518 4542
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Furthermore, VirSorter and VirFinder were previously
evaluated using simulated metagenomes that were gen-
erated by sampling from reference genomes and arbi-
trary setting the proportion of viral contigs. More
specifically, the simulated metagenome dataset in Vir-
Sorter was generated by sampling from bacterial ge-
nomes and viral genomes available in public databases,
which represent a small proportion of phage contigs, as
most phage contigs in natural metagenomes have not
been annotated [24, 25]. In VirFinder, each contig of
simulated metagenome was definitively assigned as pro-
karyotic (88%), viral (10%), or ambiguously chimeric
(1.8%) [18]. We further illustrated the different composi-
tions of simulated metagenomic data used in VirFinder
and our real metagenomic data generated here from
eight individuals under antibiotic treatment and two
controls (Additional file 3: Table S3). The average pro-
portion of phage contigs was approximately 2% (putative
phage contigs/all contigs), which was lower than in the
simulated metagenomics dataset.
The predictive performances of the three tools (VirMi-
ner, VirSorter, and VirFinder) were evaluated using our
co-assembled metagenomic and phageomic contigs in
different lengths (Table 2, Fig. 2, Additional file 7: Table
S7, Additional file 8: Table S8, and Additional file 9:
Table S9), since both VirFinder and VirSorter show dif-
ferent predictive abilities for contigs with different
lengths [12]. As VirFinder only outputs a score indicat-
ing the possibility of the contig belonging to phage, stat-
istical measure p value and corresponding corrected p
values (FDR), users have to arbitrarily set a threshold to
determine a list of identified phage contigs. We used five
different cutoffs including four commonly used cutoffs
(FDR < 0.01, 0.05, 0.1, and 0.15) and the value at which
VirFinder can achieve the same false positive rate (FPR)
as VirSorter (Table 2 and Table 3). For contigs longer
than 5 kb, when we focused on the sensitivity and speci-
ficity measured based on reads ratio mapped to correctly
predicted contigs, VirMiner showed higher sensitivity
(65.23% ± 16.94%), precision (40.04% ± 17.46%), F1 score
(0.47 ± 0.16), accuracy (77.33% ± 4.95%), and MCC (Mat-
thews correlation coefficient) (0.70 ± 0.28) compared to
VirFinder, at almost the same specificity (79.50% ±
6.46%) (Additional file 7: Table S7). In the comparison
with VirSorter, VirMiner showed much higher sensitivity
and F1 score but slightly lower specificity and accuracy,
with lower precision and nearly the same MCC. In terms
of the number of correctly predicted contigs, VirMiner
showed slightly lower performance than VirFinder when
FDR was set to 0.15 (Additional file 7: Table S7). VirSor-
ter showed much higher specificity, precision, F1 score,
MCC, and accuracy but much lower sensitivity. For con-
tigs longer than 1 kb and 3 kb, similar numbers were ob-
tained (Additional file 8: Table S8 and Additional file 9:
Table S9). These results indicated that VirMiner is more
sensitive to identify high-abundance phage contigs than
VirSorter and VirFinder.
We also examined the prediction ability of the three
tools on the identification of high-abundance phage con-
tigs. VirMiner captured more highly-abundance phage
contigs than the other two tools (Fig. 3a). In addition,
we investigated the consistency of the true positive con-
tigs identified by the three tools (Fig. 3b). For long con-
tigs (> 5 kb), VirMiner identified 1513 true positive
phage contigs, which is remarkably more than 875 and
490 contigs identified by VirSorter and VirFinder, re-
spectively (with FDR < 0.0220714, at the same FPR as
VirSorter). Notably, 67.96% (333) of phage contigs iden-
tified by VirFinder and 70.06% (613) by VirSorter were
included in the list of 1513 phage contigs that VirMiner
identified (Fig. 3b). The results for contigs > 1 kb and
contigs > 3 kb also revealed that VirMiner detected the
most true positive phage contigs among the three tools,
and more than 50% of true positive phage contigs identi-
fied by VirSorter and VirFinder were captured by VirMi-
ner. These results indicate that VirMiner has
outstanding performance in the high-abundance phages.
Application of VirMiner in an independent cohort of
humans treated with antibiotics
VirMiner was applied to an independent cohort of pre-
viously published human gut microbiome samples [43].
The samples treated with antibiotics can be divided into
three groups (“exposed 0,” “exposed 7,” and “exposed
90”). Correspondingly, the control samples also had
three subgroups (“control 0,” “control 7,” and “control
90”). A total of 5,075,513 contigs were obtained and
458,347 long contigs (> 5 kb) were retained for down-
stream analyses. Among these contigs, 62,253 were
identified as phage contigs (Additional file 10: Table
Table 2 Comparison of functionality for VirMiner (developed here), VirFinder [12], VirSorter [26], and iVirus [56]
Tools Input raw
reads
Functional
annotation
Phage contig
identification
Inter-group
comparison
Phage-host relationship
prediction
Taxonomy
analysis
VirMiner ✔ ✔ ✔ ✔ ✔ ✔
VirSorter ✖ ✔ ✔ ✖ ✖ ✖
VirFinder ✖ ✖ ✔ ✔ ✖ ✖
iVirus ✔ ✔ ✔ ✖ ✖ ✔
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S10). Further, 56,759 contigs were assigned to six
genera by the RDP classifier including T4virus,
Rslunavirus, Phikzvirus, Spn3virus, Bxz1virus, and
Agrican357virus. In addition, 33,510 contigs were
assigned to 11 species, with estimated confidence level
of > 0.5.
We estimated the microbial diversity at the genus level
and observed that the alpha diversity of the phage com-
munities in baseline (“exposed 0”) was significantly
higher than the samples exposed to antibiotics for 7 days
(“exposed 7”) (Wilcoxon test, Shannon index: p < 0.044)
(Fig. 4a). No significant difference of alpha diversity was
A B
Fig. 2 Performance comparison of VirMiner, VirSorter, and VirFinder for long contigs (> 5 kb). The predictive performance was measured based on
reads ratio of correctly predicted contigs (a) and the number of correctly predicted contigs (b). The predictive performance of VirFinder was
evaluated with five different cutoffs including four commonly used cutoffs (FDR < 0.01, 0.05, 0.1, and 0.15) and the value at which VirFinder can
achieve the same false positive rate (FPR) as VirSorter (FDR < 0.0220714)
A
B
Fig. 3 True positive phage contigs identified by VirMiner, VirSorter, and VirFinder for contigs > 1 kb, 3 kb, and 5 kb. Box plots showing abundances
of true positive phage contigs identified by the three tools (a). Only true positive phage contigs with relative abundance > 0.001 were selected
for visualization. Abundance of phage contigs referred to the ratio of reads represented by contigs over total reads in the sample. Venn diagram
showing the overlap of true positive phage contigs identified by the three tools, for contigs > 1 kb, 3 kb, and 5 kb, respectively (b)
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observed in the other two comparisons: “exposed 0” vs.
“exposed 90” and “exposed 7” vs. “exposed 90”. These re-
sults indicated that the alpha-diversity of phage communi-
ties recovered to almost the pre-treatment status at 90
days after the end of the treatment. The taxonomic eve-
ness within phage communities was not significantly dif-
ferent among these three groups (Fig. 4c). No significant
differences in microbial diversity were observed among
different time points in non-exposed participants.
We found more functional categories that have differen-
tial abundance between time points in antibiotic-exposed
participants than in control individuals. In the comparison
to functional categories between “exposed 0” vs “exposed
7” samples, 122 KO groups and 118 Pfam groups were
found with differentiated abundances (Wilcoxon rank-
sum test, p < 0.05) (Additional file 11: Table S11). Among
these functional groups, some are highly relevant to
phages including CRISPR, multidrug resistance, and pro-
tein transport. Such alterations in these functional groups
were possibly induced by antibiotic treatment [45, 46]. On
the other hand, in control individuals, only 15 KO groups
and 12 Pfam groups had differential abundance in the
comparison between “control 0” and “control 7” (p < 0.05).
Moreover, these functional groups were mainly associated
with glutathione metabolism, carbon metabolism, alanine
metabolism, and cell motility. These results indicated that
VirMiner could capture the phage functions altered by
exposure to different conditions such as antibiotic
treatment.
In the phage-host relationship prediction, 49,177
CRISPR-spacers were identified from 3,248,978 bacterial
contigs and 2766 identified spacers showed exact
matches with identified phage contigs. VirMiner pre-
dicted a total of 188 phage-host contig pairs from these
results. Then the taxonomic classification of phage con-
tigs and bacterial contigs were combined from the out-
put of VirMiner to produce the phage-host interaction
network (Fig. 5 and Additional file 19: Figure S1). In the
antibiotic-treated participants, VirMiner identified six
phage species with 35 different bacterial hosts (Add-
itional file 12: Table S12). Except for Prochlorococcus
phage P-SSM2 that was uniquely identified in participant
P18 at the 90th day after the end of treatment, five
phage species were also identified in the control sam-
ples, most of which belong to Pseudomonas phages and
Erwinia virus phages. They all have a very broad host
range, for example, Pseudomonas phages are connected
with bacterial taxa from different orders including Bac-
teroidales, Clostridiales, Enterobacterales, and Burkhol-
deriales. It is consistent with previous reports that
Pseudomonas phages infect their hosts Pseudomonas
and bacteria from other orders such as Burkholderiales
[47], which have been suggested to be positively corre-
lated to their metabolic diversity and multiple antibiotic
resistance [48, 49]. Some of these phages have already
been incorporated into phage therapy cocktails and are
continuously being examined for novel therapeutic ap-
plications [50, 51].
A B C
Fig. 4 Box plot showing genus-level microbial diversity of phages based on the independent cohort of humans treated with antibiotics. The
microbial diversity was measured by diversity indices including the Shannon index (a), Simpson index (b), and Pielou eveness index (c). Data are
shown based on three conditions before treatment, at the end of treatment and at 90 days after the end of treatment. The alpha diversity of
before-treatment (“exposed 0”) phage communities was significantly higher compared to group exposed to antibiotics for 7 days (“exposed 7”)
(Wilcoxon test; Shannon index, p < 0.044)
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In addition, our results also indicated that some
phage-host interactions were highly specific to an indi-
vidual. For example, the associations of Pseudomonas
phage 201phi2-1 with the hosts Bacteroidales bacterium
and Odoribacter splanchnicus were observed across mul-
tiple samples derived from P14. The interaction between
Pseudomonas phage 201phi2-1 and Ruminococcus bicir-
culans was captured only in P13. Another case was the
connection between Erwinia virus Deimos and Alloacti-
nosynnema sp. from P21. These findings reveal that par-
ticular patterns of phage-host interactions, which are
not affected by antibiotics treatment, are present only in
certain individuals, consistent with the findings of per-
sonalized microbiomes observed at the prokaryotic and
virus level in previous studies [1, 52, 53].
We also examined the dynamics of phage-host interac-
tions in response to antibiotic treatment. At “exposed 7”
sample, the connection between Pseudomonas phage
201phi2-1 and Lachnoclostridium sp. was observed in
three participants (Fig. 5a). Notably, Raymond et al. also
reported that Lachnoclostridium significantly increased in
16 of the 18 antibiotic-exposed participants [43]. There-
fore, we inferred that Pseudomonas phage may be sub-
stantially impacted by antibiotic therapy. We also found
some phage-host associations to remain stable throughout
the time points in the control samples. For example, the
association of Pseudomonas phage 201phi2-1 with the
hosts Parabacteroides was observed across various time
points (“control 0,” “control 7,” and “control 90”) in indi-
viduals P6 and P8 (Fig. 5b).
Discussion
Phages are believed to act as modulators of microbiota
composition and agents that drive bacterial speciation in
complex bacterial communities [54]. With the rapid in-
crease of metagenomic datasets, there is a need to de-
velop more powerful tools to analyze the taxonomic
composition and functionality of phages within the
microbiome communities and to achieve a deeper un-
derstanding of phage-host interactions. Currently, only a
few tools are available for phage analysis in mixed phage
and bacterial communities. The functionality that they
provide is limited, especially the lack of in-depth down-
stream analysis to reveal the role of phages in metagen-
ome and their responses to certain stress such as
antibiotics treatment or disease status. We developed
VirMiner to fill this gap. VirMiner identified the phage
contigs, which were functionally annotated with POGs,
viral protein families and viral hallmark genes, as well as
commonly used databases such as KO and Pfam. More-
over, VirMiner supports two-group comparison when
the input (metagenomic samples) cover different condi-
tions (e.g., case and control). Importantly, VirMiner can
A
B
Fig. 5 The phage-host interaction network produced from the independent cohort of humans treated with antibiotics at phage species level.
The phage-host network was produced from antibiotics-exposed subjects that were divided into three groups (“exposed 0,” “exposed 7,” and
“exposed 90”) (a) and control subjects that also had three groups (“control 0,” “control 7,” and “control 90”) (b). Phage (red) and bacteria (gray) are
connected if the bacteria species were predicted as the host of phages. The edge color indicates the individual’s id where the phage-host
interaction was observed
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predict phage-host interactions, providing novel insights
into the effect of phage on pathogenicity.
VirMiner also improved the predictive ability to detect
phage contigs using an RF model. VirMiner is able to
capture more highly-abundance phage contigs compared
to VirSorter [26] and VirFinder [12]. When evaluating
the predictive performance, we mainly focused on how
much “abundance of phage” (represented by the ratio of
reads mappable to phage contigs) could be predicted
correctly, which was, in our opinion, more important
than the previous metric, namely “the number of phage
contigs correctly predicted.” The rationale behind the
traditional measure is treating each contig as equally im-
portant. Compared to this, adopting the strategy that
weights each contig based on the number of mappable
reads, which is taken as a proxy of the abundance of the
corresponding sequence on the contig, we believe is
more biologically meaningful. VirMiner identified highly
abundant phage contigs, which could play key roles in
infecting bacteria and modulating microbial community
dynamics.
Sensitivity and specificity are commonly used perform-
ance measurements, which approximate the probability
of positive/negative (in our case, phage contigs/non--
phage contigs) labels being true. For classification prob-
lems, there are inevitable trade-offs between sensitivity
and specificity. In our human gut metagenome samples
that were used to build the model of phage contigs iden-
tification, the putative non-phage contigs were much
more than phage contigs (Additional file 3: Table S3).
Thus, we attempted to improve sensitivity at the cost of
slightly decreased precision and specificity. As a result,
VirSorter and VirFinder tend to predict non-phage con-
tigs more precisely while VirMiner is more sensitive to
detect phage contigs with relatively high abundance at
an acceptable specificity.
We also tested other strategies to identify phage con-
tigs. According to Paez-Espino et al. [24], a metagenomic
contig identified as viral should meet at least one of the
following three conditions: (1) the contig has at least five
hits to viral protein families, less than 20% total genes
on the contig are annotated to KO terms, less than or
equal to 40% total genes are annotated with Pfams, and
more than 10% genes are mapped to viral protein fam-
ilies; (2) the number of viral protein families on the con-
tig is equal or higher than the number of Pfams; and (3)
≥ 60% genes identified as viral protein families. When
we used this strategy to identify high-abundance phage
contigs, the performance showed much lower sensitivity
than VirMiner at almost the same specificity, probably
because for the strategy in Paez-Espino et al. [24], less
information was used to characterize phage contigs
compared to VirMiner (Additional file 13: Table S13).
We also attempted to add k-mer frequency profiles as
metrics to train the RF model. This approach increased
the specificity for identification of both high-abundance
phage contigs and the count of phage contigs, but the
sensitivity dropped dramatically. Based on these bench-
marking activities, we consider VirMiner an important
tool for analyzing phage dynamics in metagenomic
datasets.
We also assessed the robustness of the VirMiner pre-
dictive model when used for the identification of viral
contigs from other environmental data. A subset of pub-
licly available paired viral-microbial metagenomic data
from the Tara Oceans samples (40 samples in total),
which were included in the study of Sunagawa et al.
[55], was used as an independent test set (Add-
itional file 14: Table S14). The phage contigs in each
metagenomic sample were identified using the VirMiner
predictive model. We used the same methodology de-
scribed in the manuscript to define three categories for
the metagenomic contigs (phage contigs, ambiguous
contigs, and confident non-phage contigs) for predictive
performance evaluation. As a result, VirMiner achieved
45.85% ± 15.26% sensitivity and 92.22% ± 4.24% specifi-
city in the prediction of phage contigs from the Tara
dataset. In particular, for the high-abundance phage con-
tigs, VirMiner reached 53.37% ± 21.91% sensitivity at
high specificity (89.21% ± 8.77%) (Additional file 15:
Table S15). These results indicate that the VirMiner pre-
dictive model is robust and sensitive when it is applied
for the identification of viral contigs from other than hu-
man gut environmental microbiomes.
Besides the above analysis, we attempted to construct
the RF predictive model using mixed Tara Ocean sam-
ples and human gut metagenomic data. The result of re-
peated fivefold cross-validation 10 times showed 57.05%
± 4.55% sensitivity and 80.19 ± 2.09% specificity in the
prediction of phage contigs. In particular, for the
high-abundance phage contigs, it showed 60.94% ±
7.31% sensitivity and 82.89% ± 2.69% specificity (Add-
itional file 16: Table S16). Our findings indicated that
the RF-based predictive model for viral contig identifica-
tion is basically independent of the environmental
microbiome. Another attempt was to train the RF pre-
dictive model only with the Tara Oceans metagenomic
samples and test its performance with the dataset from
the human gut samples. This RF model showed much
lower sensitivity and specificity than VirMiner (Add-
itional file 17: Table S17). One of the possible reasons is
that there is much more noise presented in the Tara
Oceans samples. Using the VirMiner pipeline, the quality
control report of the metagenomic raw reads showed
that 12 out of 40 samples have more than 10%
low-quality sequences while in our human gut metage-
nomic samples that were used for the VirMiner training
dataset, of 59 samples, only one sample contains more
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than 10% low-quality sequences (Additional file 18:
Table S18 and Additional file 19). Therefore, we con-
cluded that the predictive model of VirMiner outper-
formed RF-based models based solely on the Tara
Oceans data.
Conclusions
In summary, we developed VirMiner based on actual
phageomics and microbial metagenomics samples to fill
this gap. Compared to VirSorter and VirFinder (the
most widely used tools), VirMiner is able to capture
more highly abundant phage contigs, which could play
key roles in infecting bacteria and influencing microbial
community dynamics. Moreover, VirMiner is a compre-
hensive tool for phage analysis in metagenomic samples.
It supports statistical comparison among different
groups (e.g., case and control). Importantly, VirMiner
can predict phage-host interactions, providing novel in-
sights into the effect of phage on pathogenicity. Our ex-
ample application of VirMiner to an independent cohort
of previously published human gut microbiome samples
highlights its utility in exploring the dynamics of func-
tional profiles in phage communities and phage-host in-
teractions in response to antibiotic treatment.
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